NIH-CSR <script type="text/javascript"> var wmNotice = "UNT Web Archive - External links, forms, and search boxes may not function within this collection. Url: http://cms.csr.nih.gov/PeerReviewMeetings/CSRIRGDescriptionNew/SBIBIRG/SBIB13.htm time: 20:13:19 Jan 30, 2009"; var wmHideNotice = "hide"; var contextRoot = "https://webarchive.library.unt.edu/eot2008/"; </script> <script type="text/javascript" src="https://webarchive.library.unt.edu/eot2008/js/disclaim.js"></script> <span id="Postingname3_PostingDisplayName">Small Business Novel Technologies for In Vivo Imaging and Image-guided Cancer Interventions [SBIB (13)]</span> (SBIBIRG)


search

Small Business Novel Technologies for In Vivo Imaging and Image-guided Cancer Interventions [SBIB (13)]

[SBIR/STTR Rosters]

This Special Emphasis Panel reviews applications dealing with the development and delivery of novel in vivo cancer-specific image acquisition or enhancement technologies and methods for biomedical imaging and image-guided interventions and therapy for cancer.

Specific areas covered by SBIB (13):

Novel single and multi-modality molecular imaging and spectroscopy systems
Novel single and multimodality anatomical and functional imaging systems, methods, agents, and related software
Development and optimization of efficient imaging systems for cancer screening
Imaging for diagnosis, staging, or monitoring the effects of cancer therapy
Image-guided biopsy (IGB), Image-guided therapy (IGT), and Image-guided interventional (IGI) procedures

SBIB (13) has the following shared interests outside the SBIB IRG:

With Radiation Biology and Therapeutics Special Emphasis Panel [ONC (11)]: In general, development and testing of imaging devices and nuclear medicine technologies for cancer diagnosis should be assigned to SBIB (13). Studies of radiotherapy for the treatment of cancer would be assigned to RBT [ONC (11)].